Literature DB >> 12196109

Adrenomedullin: receptor and signal transduction.

D M Smith1, H A Coppock, D J Withers, A A Owji, D L Hay, T P Choksi, P Chakravarty, S Legon, D R Poyner.   

Abstract

Adrenomedullin is a vascular tissue peptide and a member of the calcitonin family of peptides, which includes calcitonin, calcitonin-gene-related peptide (CGRP) and amylin. Its many biological actions are mediated via CGRP type 1 (CGRP(1)) receptors and by specific adrenomedullin receptors. Although the pharmacology of these receptors is distinct, they are both represented in molecular terms by the type II family G-protein-coupled receptor, calcitonin-receptor-like receptor (CRLR). The specificity here is defined by co-expression of receptor-activity-modifying proteins (RAMPs). CGRP(1) receptors are represented by CRLR and RAMP1, and specific adrenomedullin receptors by CRLR and RAMP2 or 3. Here we discuss how CRLR/RAMP2 relates to adrenomedullin binding, pharmacology and pathophysiology, and how chemical cross-linking of receptor-ligand complexes in tissue relates to that in CRLR/RAMP2-expressing cells. CRLR, like other type II family G-protein-coupled receptors, signals via G(s) and adenylate cyclase activation. We demonstrated that adrenomedullin signalling in cell lines expressing specific adrenomedullin receptors followed this expected pattern.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196109     DOI: 10.1042/bst0300432

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  8 in total

1.  Pancreatic cancer-associated diabetes is an "exosomopathy".

Authors:  Murray Korc
Journal:  Clin Cancer Res       Date:  2015-02-02       Impact factor: 12.531

Review 2.  SPECT and PET imaging of adrenomedullin receptors: a promising strategy for studying pulmonary vascular diseases.

Authors:  Luis Michel Alonso Martinez; François Harel; Myriam Létourneau; Vincent Finnerty; Alain Fournier; Jocelyn Dupuis; Jean N DaSilva
Journal:  Am J Nucl Med Mol Imaging       Date:  2019-10-15

Review 3.  Adrenomedullin in lymphangiogenesis: from development to disease.

Authors:  Klara R Klein; Kathleen M Caron
Journal:  Cell Mol Life Sci       Date:  2015-05-08       Impact factor: 9.261

Review 4.  Regulation and Dysregulation of Endothelial Permeability during Systemic Inflammation.

Authors:  Katharina E M Hellenthal; Laura Brabenec; Nana-Maria Wagner
Journal:  Cells       Date:  2022-06-15       Impact factor: 7.666

5.  Adrenomedullin-2/intermedin induces cAMP accumulation in dissociated rat spinal cord cells: evidence for the existence of a distinct class of sites of action.

Authors:  Ali Akbar Owji; Jean-Guy Chabot; Yvan Dumont; Rémi Quirion
Journal:  J Mol Neurosci       Date:  2008-04-17       Impact factor: 3.444

6.  Adrenomedullin Inhibits Osmotic Water Permeability in Rat Inner Medullary Collecting Ducts.

Authors:  Fuying Ma; Guangping Chen; Eva L Rodriguez; Janet D Klein; Jeff M Sands; Yanhua Wang
Journal:  Cells       Date:  2020-11-24       Impact factor: 6.600

7.  Adrenomedullin in ovarian cancer: foe in vitro and friend in vivo?

Authors:  Cinzia Baranello; Marisa Mariani; Mirko Andreoli; Mara Fanelli; Enrica Martinelli; Gabriella Ferrandina; Giovanni Scambia; Shohreh Shahabi; Cristiano Ferlini
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

8.  Anterior Pituitary Transcriptome Suggests Differences in ACTH Release in Tame and Aggressive Foxes.

Authors:  Jessica P Hekman; Jennifer L Johnson; Whitney Edwards; Anastasiya V Vladimirova; Rimma G Gulevich; Alexandra L Ford; Anastasiya V Kharlamova; Yury Herbeck; Gregory M Acland; Lori T Raetzman; Lyudmila N Trut; Anna V Kukekova
Journal:  G3 (Bethesda)       Date:  2018-03-02       Impact factor: 3.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.